Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28394988 | 0.83 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1 | |
| SCHEMBL4060738 | 0.77 | — | — | |
| SCHEMBL9100777 | 0.71 | — | — | |
| SCHEMBL29289510 | 0.65 | MEN1 (0.36) | — | |
| SCHEMBL11787834 | 0.65 | MEN1 (0.36) | — | |
| SCHEMBL2573184 | 0.62 | MEN1 (0.33) | — | |
| SCHEMBL21408512 | 0.60 | — | — | |
| SCHEMBL9947423 | 0.58 | TSHR (0.30) | TSHR | |
| SCHEMBL133022 | 0.57 | MEN1 (0.75) | ALDH1A1TSHRTDP1 | |
| SCHEMBL2905909 | 0.57 | MEN1 (0.75) | ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116082100-B | Preparation method of ordered micropore emission charge | 西安近代化学研究所 | 2024-05-10 | — | — | CN | claimed |
| CN-116082100-A | Preparation method of ordered micropore emission charge | 西安近代化学研究所 | 2023-05-09 | — | — | CN | claimed |
| CN-114685227-B | Preparation method of TNBA/TNAZ eutectic | 中北大学 | 2023-04-28 | — | — | CN | claimed |
| CN-114685226-B | Light-cured intelligent energetic material and preparation method thereof | 西安近代化学研究所 | 2022-12-13 | — | — | CN | claimed |
| CN-110232241-B | Hemispherical fusion-cast explosive casting process simulation method | 西安近代化学研究所 | 2022-10-25 | — | — | CN | claimed |
| CN-110713428-B | Casting type high polymer bonded explosive | 湖北航天化学技术研究所 | 2021-07-23 | — | — | CN | claimed |
| CN-110713428-A | Casting type high polymer bonded explosive | 湖北航天化学技术研究所 | 2020-01-21 | — | — | CN | claimed |
| US-10184326-B2 | Perforating system for hydraulic fracturing operations | BAKER HUGHES, A GE COMPANY LLC (US) | 2019-01-22 | — | — | US | claimed |
| US-20150361774-A1 | Perforating System for Hydraulic Fracturing Operations | BAKER HUGHES HOLDINGS LLC | 2015-12-17 | — | — | US | claimed |
| US-20120210967-A1 | ANAEROBIC DEFLAGRATION INTERNAL PISTON ENGINES, ANAEROBIC FUELS AND VEHICLES COMPROSING THE SAME | WALDHORN JOSHUA (IL) | 2012-08-23 | — | — | US | claimed |
| WO-2009022350-A2 | ENGINE AND METHODS THEREOF | WALDHORN JOSHUA (IL) | 2009-02-19 | — | — | WO | claimed |
| EP-1982058-A2 | ANAEROBIC DEFLAGRATION INTERNAL PISTON ENGINES, ANAEROBIC FUELS AND VEHICLES COMPRISING THE SAME | Waldhorn, Joshua (IL) | 2008-10-22 | — | — | EP | claimed |
| WO-2008102343-A1 | APPARATUS AND METHOD FOR REDUCING FRICTION, CORROSION AND BIOLOGICAL GROWTH ON THE HULL OF MARINE VESSELS | WALDHORN JOSHUA (IL) | 2008-08-28 | — | — | WO | claimed |
| EP-1556056-A4 | X-NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEROF | RADIORX INC (US) | 2008-08-06 | — | — | EP | claimed |
| WO-2007091270-A2 | ANAEROBIC DEFLAGRATION INTERNAL PISTON ENGINES, ANAEROBIC FUELS AND VEHICLES COMPRISING THE SAME | WALDHORN JOSHUA (IL) | 2007-08-16 | — | — | WO | claimed |
| EP-1556056-A2 | X-NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEROF | Radiorx, Inc. (US) | 2005-07-27 | — | — | EP | claimed |
| US-20040167212-A1 | X-nitro compounds, pharmaceutical compositions thereof and uses thereof | RADIORX, INC. | 2004-08-26 | — | — | US | claimed |
| WO-2004032864-A2 | X-NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEROF | RADIORX, INC. (US) | 2004-04-22 | — | — | WO | claimed |
| WO-1996036602-A1 | ADNAZ, COMPOSITIONS AND PROCESSES | THE UNITED STATES OF AMERICA (US) | 1996-11-21 | — | — | WO | claimed |
| US-5476951-A | Nitration of 3-oximoazetidine | GEO-CENTERS, INC. | 1995-12-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167212-A1 | X-nitro compounds, pharmaceutical compositions thereof and uses thereof | XDH, TXN, NOX1 | ALDH1A1 2041/4885TSHR 3847/4885TDP1 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.